ArticleJCI insight2021

PD-1 blockade counteracts post-COVID-19 immune abnormalities and stimulates the anti-SARS-CoV-2 immune response.

Cristian Loretelli et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.